SCHEMBL2632758

SCHEMBL2632758

CCc1nc(C)cc(Cl)n1

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HTT P42858 4/20 0.44
LMNA P02545 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.38
KMT2A Q03164 5/20 0.38
ALDH1A1 P00352 1/20 0.35
MAPK1 P28482 1/20 0.35
CYP1A2 P05177 1/20 0.33
CASP1 P29466 1/20 0.33
GAA P10253 1/20 0.33
S1PR4 O95977 1/20 0.33
MEN1 O00255 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ADORA1 P30542 1/20 0.32
MAPT P10636 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29826849 1.00 HTT (0.44) HTTLMNASMN1; SMN2KMT2AALDH1A1
Propane SCHEMBL10924005 0.86 HTT (0.36) HTTLMNASMN1; SMN2KMT2AALDH1A1
SCHEMBL1319508 0.85 KMT2A (0.38) HTTLMNASMN1; SMN2KMT2AMAPK1
SCHEMBL11077413 0.84 HTT (0.50) HTTLMNASMN1; SMN2KMT2AALDH1A1
SCHEMBL2937637 0.83 HTT (0.48) HTTLMNAKMT2AMAPK1GAA
SCHEMBL1671889 0.83 HTT (0.42) HTTLMNASMN1; SMN2KMT2AALDH1A1
SCHEMBL22655940 0.80 HTT (0.43) HTTLMNASMN1; SMN2KMT2AALDH1A1
SCHEMBL3281802 0.79 HTT (0.40) HTTLMNASMN1; SMN2KMT2AALDH1A1
SCHEMBL11763467 0.78 HTT (0.39) HTTLMNASMN1; SMN2KMT2AALDH1A1
SCHEMBL22655937 0.77 NOS3 (0.38) SMN1; SMN2KMT2AALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240158392-A1 SMALL MOLECULE INHIBITORS OF SALT INDUCIBLE KINASES JANSSEN RESEARCH & DEVELOPMENT, LLC 2024-05-16 US disclosed
EP-4284801-A1 SMALL MOLECULE INHIBITORS OF SALT INDUCIBLE KINASES Janssen Biotech, Inc. (US) 2023-12-06 EP disclosed
WO-2023014611-A1 PYRIMIDINE COMPOUNDS AND USE THEREOF YEH, TENG-KUANG (US) 2023-02-09 WO disclosed
WO-2022165529-A1 SMALL MOLECULE INHIBITORS OF SALT INDUCIBLE KINASES JANSSEN BIOTECH, INC. (US) 2022-08-04 WO disclosed
US-20210198277-A1 AMINE-SUBSTITUTED ARYL OR HETEROARYL COMPOUNDS Epizyme, Inc. 2021-07-01 US disclosed
EP-3332645-A1 USE OF SUBSTITUTED PYRIMIDINE DIONES OR THEIR SALTS AS AGENTS TO COMBAT ABIOTIC PLANT STRESS Bayer Cropscience AG (DE) 2018-06-13 EP disclosed
US-8163763-B2 Pyrimidine compounds, compositions and methods of use GENENTECH, INC. (US) 2012-04-24 US disclosed
WO-2009007115-A1 TROPANE DERIVATIVES USEFUL AS PESTICIDES SYNGENTA PARTICIPATIONS AG (CH) 2009-01-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240158392-A1 SMALL MOLECULE INHIBITORS OF SALT INDUCIBLE KINASES SIK2, SIK1, SGK2 HTT 3602/4885LMNA 2925/4885SMN1; SMN2 3223/4885
US-20210198277-A1 AMINE-SUBSTITUTED ARYL OR HETEROARYL COMPOUNDS SHMT1, BHMT, BHMT2 HTT 107/4885LMNA 3564/4885SMN1; SMN2 504/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.